What is Vault Pharma?
Vault Pharma is dedicated to developing precision therapies for a range of challenging conditions, including cancer, infectious diseases, and auto-immune disorders. Its proprietary platform utilizes human vault particles to effectively introduce targeted substances to the immune system, aiming to enhance the body's defense mechanisms against disease. The company actively engages in collaborations with pharmaceutical companies, academic institutions, and government bodies to accelerate its drug discovery and development efforts. With a pipeline that includes initiatives targeting critical health issues such as COVID-19, Vault Pharma is at the forefront of therapeutic innovation.
How much funding has Vault Pharma raised?
Vault Pharma has raised a total of $56K across 1 funding round:
Debt
$56K
Debt (2021): $56K with participation from PPP
What's next for Vault Pharma?
The substantial expansion capital infusion signifies a critical phase for Vault Pharma, likely enabling the company to advance its pipeline candidates through further clinical development and scale its operational capabilities. This strategic financing at the Series B/C stage suggests a focus on achieving key milestones, potentially including IND submissions, expanded clinical trials, and strategic partnerships. Vault Pharma's commitment to precision therapies in immunology positions it to address unmet medical needs and capitalize on the growing demand for targeted treatment modalities in oncology and infectious diseases.
See full Vault Pharma company page
